Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554671 · ClinicalTrials.gov registry record · NA
Pharmacist-led Group Medical Visits to Help With Diabetes Management
A NA study of Cardiovascular Diseases and Diabetes Mellitus, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 3
- Study locations
NCT00554671: Completed NA study of Cardiovascular Diseases and Diabetes Mellitus, sponsored by VA Office of Research and Development.
NCT00554671 is a NA study of Cardiovascular Diseases and Diabetes Mellitus that has completed, run by VA Office of Research and Development. The registered enrollment target is 250 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00554671, a NA study of Cardiovascular Diseases and Diabetes Mellitus, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a multi-site open label randomized controlled study of patients with type 2 diabetes undergoing pharmacist-led group medical visits that include education by a multi-disciplinary personnel, behavioral modification and pharmacotherapy case management vs. usual care
Primary Outcome
Hemoglobin A1c levels at 6 months
Conditions Studied
Interventions
- BEHAVIORAL Monitoring
- OTHER Algorithm driven medication titration
- BEHAVIORAL Group support
- BEHAVIORAL Self efficacy
Study Locations (3)
Connecticut
- VA Connecticut Health Care System (West Haven) - West Haven
Hawaii
- VA Pacific Islands Health Care System, Honolulu - Honolulu
Rhode Island
- Providence VA Medical Center, Providence, RI - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT00554671 record still lists
NCT00554671 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Monitoring is the first listed.
NCT00554671 reports a single indexed study location in Connecticut, Hawaii, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00554671 about?
NCT00554671 is a clinical study titled "Pharmacist-led Group Medical Visits to Help With Diabetes Management". This is a multi-site open label randomized controlled study of patients with type 2 diabetes undergoing pharmacist-led group medical visits that include education by a multi-disciplinary personnel, behavioral modification and pharmacotherapy case management vs. usual care
What is the current status of trial NCT00554671?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2008-05. Estimated completion is 2012-06.
What conditions does trial NCT00554671 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Diabetes Mellitus.
What interventions are being tested in trial NCT00554671?
The interventions under investigation include: Monitoring (BEHAVIORAL), Algorithm driven medication titration (OTHER), Group support (BEHAVIORAL), Self efficacy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00554671?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00554671 being conducted?
This trial has 3 study locations across Connecticut, Hawaii, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00554671's enrollment target sits among peer trials
250 133rd of 300 higher than 164 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia